STOCK TITAN

Raymond James (NYSE: RJF) Executive Chair acquires shares from RSU and PRSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Raymond James Financial executive reports stock awards vesting. A reporting person who serves as both a director and Executive Chair of Raymond James Financial, Inc. (RJF) disclosed the acquisition of company common stock through equity awards. On 12/02/2025, the individual acquired 105,657 shares of common stock and an additional 59,916 shares, both at a stated price of $0.0000 per share, following the vesting of previously granted performance restricted stock units and restricted stock units. After these transactions, the reporting person directly beneficially owned 426,120 shares of common stock and indirectly held 1,998 shares through an Employee Stock Ownership Plan account as of November 24, 2025.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
REILLY PAUL C

(Last) (First) (Middle)
880 CARILLON PARKWAY

(Street)
ST. PETERSBURG FL 33716

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RAYMOND JAMES FINANCIAL INC [ RJF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Chair
3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/02/2025 A 105,657(1) A $0.0000 366,204 D
Common Stock 12/02/2025 A 59,916(1) A $0.0000 426,120 D
Common Stock 1,998(2) I ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Vesting of Performance Restricted Stock Units (PRSUs) granted on 12/15/2022.
2. Includes shares of common stock acquired under the reporting person's Employee Stock Ownership Plan (ESOP) account through November 24, 2025.
Remarks:
This Form 4 reports the acquisition by the reporting person of common stock resulting from the vesting of Restricted Stock Units (RSUs) granted on 12/15/2022 based on the company's attaining certain levels of average after-tax return-on-equity, as modified by the company's relative total shareholder return compared to a peer group, over a three-year measurement period.
/s/ Paul C. Reilly by Jonathan J. Doyle as Attorney-in-Fact 12/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RJF report in this Form 4?

The filing reports that a Raymond James Financial director and Executive Chair acquired 105,657 shares and 59,916 shares of common stock on 12/02/2025 upon vesting of equity awards.

What type of equity awards vested for the RJF insider?

The insider’s acquisition resulted from the vesting of Performance Restricted Stock Units (PRSUs) and Restricted Stock Units (RSUs) that were granted on 12/15/2022.

At what price were the RJF shares acquired in this transaction?

The 105,657 and 59,916 Raymond James Financial common shares were reported as acquired at a stated price of $0.0000 per share in connection with the vesting of stock units.

How many RJF shares does the insider own after these transactions?

Following the reported transactions, the insider directly beneficially owned 426,120 shares of Raymond James Financial common stock and indirectly beneficially owned 1,998 shares through an ESOP account.

What performance conditions affected the RJF PRSU vesting?

The PRSUs vested based on the company attaining certain levels of average after-tax return-on-equity, adjusted by relative total shareholder return versus a peer group over a three-year measurement period.

What is the reporting person’s role at Raymond James Financial (RJF)?

The reporting person is identified as both a Director and an Officer, serving in the role of Executive Chair at Raymond James Financial, Inc.

Raymond James

NYSE:RJF

View RJF Stock Overview

RJF Rankings

RJF Latest News

RJF Latest SEC Filings

RJF Stock Data

28.35B
176.57M
Asset Management
Security Brokers, Dealers & Flotation Companies
Link
United States
ST PETERSBURG